Template:Reteplase: Difference between revisions

Revision as of 19:34, 6 February 2014

Reteplase
Retavase^® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Reteplase
ClinicalTrials.gov

@@ Line 7: / Line 7: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase dosage and administration|Dosage and Administration]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase dosage forms and strengths|Dosage Forms and Strengths]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase contraindications|Contraindications]]
@@ Line 27: / Line 25: @@
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase nonclinical toxicology|Nonclinical Toxicology]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase clinical studies|Clinical Studies]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase how supplied storage and handling|How Supplied/Storage and Handling]]
-|-
-! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase patient counseling information|Patient Counseling Information]]
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Reteplase labels and packages|Labels and Packages]]